MAZE— Maze Therapeutics, Inc.

Here is why Maze Therapeutics (MAZE) is Among the Top 8 Oversold Strong Buy-Rated Stocks

Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.

Maze Therapeutics: MZE829 Presses Forward Despite Stock Price Drop

After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)

Why Maze Therapeutics Plunged 35% Despite 'Overwhelming Positive' Data

Maze Therapeutics Shares Phase II HORIZON Data: MZE829 Cuts Proteinuria in APOL1 Kidney Disease

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B

Maze Therapeutics falls despite positive mid-stage trial data for lead asset